Literature DB >> 8175127

A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation.

Y Takahashi1, H Kumada, M Shimizu, K Tanikawa, R Kumashiro, M Omata, T Ehata, T Tsuji, M Ukida, M Yasunaga.   

Abstract

To determine the risk of death at an early stage of fulminant viral hepatitis, we created severity indexes drawn from clinical data on the day of development of encephalopathy in 128 patients with fulminant hepatitis B and 103 with fulminant hepatitis non-A, non-B. In fulminant hepatitis B, the risk score was 2.75 x BL + 2.75 x BR + 2.7 x AG + 2.3 x WB + 1.67 x CD + 1.56 x AL - 0.098 x PR - 0.88, where BL is 1 if total bilirubin is higher than 20 mg/dl, BR is 1 if the ratio of total to direct bilirubin exceeds 2.2, AG is 1 if age is above 40 yr, WB is 1 if white blood cell count is less than 4,000 cells/mm3 or more than 18,000 cells/mm3, CD is 1 if a hazardous disease coexists and AL is 1 if ALT is less than 100 times the upper limit of normal (otherwise all are 0), and PR is prothrombin time (percentage of normal value). Using a cutoff score of 0, we found the positive predictive value, negative predictive value and predictive accuracy to be 0.90, 0.86 and 0.89, respectively. Sensitivity and specificity were 0.94 and 0.77, respectively. In fulminant non-A, non-B hepatitis, the risk score was 2.66 x BR + 2.25 x BL + 2.24 x DI + 2.05 x AL +/- 1.38 x AG + 0.00021 x WB - 6.33.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175127

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  A Novel prognostic scoring system to predict 3-month mortality risk in patients with acute-on-chronic liver failure in hepatitis B: a retrospective cohort study.

Authors:  Yu-Bao Zheng; Shi-Bin Xie; Dong-Ying Xie; Liang Peng; Zi-Ying Lei; Hong Deng; Bin-Liang Lin; Chao-Shuang Lin; Zhi-Xin Zhao; Wei-Min Ke; Zhi-Liang Gao
Journal:  Hepatol Int       Date:  2012-01-29       Impact factor: 6.047

Review 2.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

3.  Serum Procalcitonin in Patients with Acute Liver Failure.

Authors:  Takaaki Sugihara; Masahiko Koda; Toshiaki Okamoto; Kenichi Miyoshi; Tomomitsu Matono; Kenji Oyama; Keiko Hosho; Jun-Ichi Okano; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

4.  Analyses of prognostic indices of chronic liver failure caused by hepatitis virus.

Authors:  Xiao-Mao Li; Lin Ma; Yue-Bo Yang; Zhong-Jie Shi; Shui-Sheng Zhou
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

5.  Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure.

Authors:  Blake Gregory; Anne M Larson; Joan Reisch; William M Lee
Journal:  J Investig Med       Date:  2010-06       Impact factor: 2.895

6.  Acute liver failure in adults: an evidence-based management protocol for clinicians.

Authors:  Heather Patton; Michael Misel; Robert G Gish
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

7.  Elevated resistive index in the hepatic artery as a predictor of fulminant hepatic failure in patients with acute viral hepatitis: a prospective study using Doppler ultrasound.

Authors:  Katsuaki Tanaka; Kazushi Numata; Manabu Morimoto; Kazuhito Shirato; Satoru Saito; Toshio Imada; Shinju Arata; Mitsugi Sugiyama
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B.

Authors:  Yasuhiro Miyake; Yoshiaki Iwasaki; Ryo Terada; Kouichi Takaguchi; Kohsaku Sakaguchi; Yasushi Shiratori
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 6.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.